Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biktarvy
Pharma
Gilead aims to shake up HIV PrEP market with long-acting launch
The HIV-focused drugmaker looks to position its long-acting Sunlenca as a prime PrEP option after the med aced a phase 3 study.
Zoey Becker
Aug 9, 2024 11:42am
GSK's Dovato matches Gilead's Biktarvy with less weight gain
Jul 23, 2024 4:00am
Fraudulent HIV med crackdown continues with criminal indictments
Jul 1, 2024 5:06pm
In switching study, patients preferred J&J, ViiV drug over rival
Jul 25, 2023 9:32am
ViiV, Gilead row escalates to feds after self-regulation fails
May 2, 2023 10:14am
Gilead handed its CEO Daniel O'Day a healthy pay bump in 2022
Mar 24, 2023 9:55am
